A COMPOSITION FOR TREATMENT OF DISEASE RELATED TO ANGIOGENESIS COMPRISING BIOCHANIN A OR PHARMACEUTICALLY ACCEPTED SALTS THEREOF

2012
OA: closed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-14 ⓘ

This patent discloses a pharmaceutical composition comprising biochanin A or its salts for suppressing angiogenesis in diseases including endometriosis, cancer, and inflammation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

PURPOSE: A composition containing biochanin A or pharmaceutically acceptable salt thereof for treating angiogenesis-associated diseases is provided to treat various diseases. CONSTITUTION: A composition for treating angiogenesis-associated diseases contains biochanin A or pharmaceutically acceptable salt thereof as an active ingredient. The angiogenesis-associated diseases are cancer, diabetetic retinopathy, rheumatic arthritis, psoriasis, inflammation, endometriosis, aging or hemandioma. A pharmaceutical composition for suppressing angiogenesis contains biochanin A or pharmaceutically acceptable salt thereof as an active ingredient.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-20T06:19:39.675353+00:00